- This weekend’s Barron’s suggests ways to play U.S.-China tensions and the stock-splitting trend.
- Other featured articles look at how the election could affect health care stocks and what to expect from big-box retail earnings.
- Also, the prospects for a pharmaceutical giant, regional bank dividends, pet stocks and more.
How to Profit From the U.S.-China Cold War" by Reshma Kapadia explains why investors should watch for certain risks and opportunities in the escalating tensions between the United States and China. Does Barron’s believe Nike Inc (NYSE: NKE) is a play?” data-reactid=”23″>How to Profit From the U.S.-China Cold War” by Reshma Kapadia explains why investors should watch for certain risks and opportunities in the escalating tensions between the United States and China. Does Barron’s believe Nike Inc (NYSE: NKE) is a play?
How to Play Stock-Split Mania" points out that when Apple Inc. (NASDAQ: AAPL) and Tesla Inc (NASDAQ: TSLA) announced stock splits, their stocks promptly rallied. Can investors expect more companies with big stock prices to follow suit?” data-reactid=”24″>Al Root’s “How to Play Stock-Split Mania” points out that when Apple Inc. (NASDAQ: AAPL) and Tesla Inc (NASDAQ: TSLA) announced stock splits, their stocks promptly rallied. Can investors expect more companies with big stock prices to follow suit?
How the 2020 Election Could Affect Health-Care Stocks," Josh Nathan-Kazis shows how a Biden and a Trump administration are likely to differ on drug pricing, health insurance and COVID-19 plans, affecting everything from CVS Health Corp (NYSE: CVS) to Moderna Inc (NASDAQ: MRNA).” data-reactid=”25″>In “How the 2020 Election Could Affect Health-Care Stocks,” Josh Nathan-Kazis shows how a Biden and a Trump administration are likely to differ on drug pricing, health insurance and COVID-19 plans, affecting everything from CVS Health Corp (NYSE: CVS) to Moderna Inc (NASDAQ: MRNA).
MRK) has a blockbuster cancer drug, a 3% dividend yield and two COVID-19 vaccine candidates in the pipeline, according to “Merck, Big Pharma’s Quiet Giant, Looks Like a Buy” by Andrew Bary.
ZTS).
PNC) and some of its peers.
HD) and other big retailers.
TGT) or Walmart Inc (NYSE: WMT) will have benefited more from the recent strength in retail when they report earnings.
Also in this week’s Barron’s:
- What comes next for Robinhood
- The bear market that really wasn’t
- How ESG investors can win without Apple and Amazon
- How stagflation looms over the market
- Whether older investors are more patient
- More signs coronavirus exacerbates economic inequality
- Why palladium prices hit a bump in the road
Keep up with all the latest breaking news and trading ideas by following Benzinga on Twitter.
View Article Origin Here
